New research presents an exciting treatment option for individuals with Alzheimer’s disease. According to the results of a recent experiment, when individuals with early stage Alzheimer’s disease consumed water rich with the element silicon every day for twelve weeks, some showed an improvement in memory and cognitive ability.
This stands out as a momentous finding, as it’s the only proposed treatment in the last 40 years that has actually decreased or altered the progression of Alzheimer’s disease. Given that Alzheimer’s disease now affects 44 million individuals around the world and has increased dramatically within the last 50 years, such a promising treatment option merits full consideration and support. Alzheimer’s disease is both debilitating and devastating; individuals that suffer from Alzheimer’s disease can experience memory loss, disorientation, trouble writing and speaking, changes in personality, difficulty thinking, and difficulty making sound decisions, among other negative consequences. Additionally, the cost of caring for an individual with Alzheimer’s disease can reach up to $30,000 a year. In short, finding a treatment for Alzheimer’s disease is incredibly urgent.
Why did the facilitators of this experiment specifically choose silicon-rich water to give individuals with Alzheimer’s disease? The answer begins with the fact that scientists have long believed that aluminum, an element known to be toxic to the human body, could negatively affect the body’s immune system, cognitive function, and genetic system. Scientists suspected that Alzheimer’s disease, with its increasing prevalence and disruption of cognitive function, could be caused by our heightened exposure to aluminum. 150 published papers over the course of the last 30 years have pointed toward such a relationship. Because aluminum is suspected to be a major cause of Alzheimer’s disease, it made sense to conduct a study with the element that helps rid the body of aluminum: silicon. Thus, by drinking water rich with silicon, individuals in the early stages of Alzheimer’s reduced their body’s aluminum content and subsequently improved their cognitive ability.
This latest finding stands out as one of the most explicit demonstrations of aluminum’s association with Alzheimer’s disease.
In response to this groundbreaking finding, organizations like the Children’s Medical Safety Research Institute are eager to demonstrate their support for this treatment option by increasing public awareness and supporting future research. Specifically, a longer, more wide-scale clinical trial of silicon-rich water is needed to provide additional support for the initial research. Leading aluminum researcher Professor Christopher Exley, who works at the premier research institution Keele University in the U.K., currently seeks funding for a study that would involve a minimum of 50 individuals to be tested over the course of 24 months. The proposed study is endorsed by leaders in the field of Alzheimer’s research, such as George Perry, Editor-in-Chief of the Journal of Alzheimer’s Disease and chair of the Neurobiology Department at the University of Texas San Antonio.
The project “The People’s Trial” has been created to raise money to ensure that Professor Exley’s study can be carried out. This crowd-funding project will run for the course of three months starting on July 14th.
Billions of dollars have already been spent on the research and development of drugs to treat Alzheimer’s disease; however, no drug has yet to be successful. Rather than continue to funnel billions into this area of research, money should be allocated to the more promising treatment of silicon-rich water. Consider, too, that not only is silicon-rich water an effective treatment option, it’s also easy, affordable, and noninvasive.
To learn more about silicon-rich water, The People’s Trial, and to support Professor Exley’s clinical trial, please visit: https://www.futsci.com/project/the-aluminium-alzheimer-s-disease-hypothesis-what-is-the-role-of-aluminium-in-alzheimers-disease.